Drugs / Probiotics Compound (Biolosion)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06904573 | Jan 2025 → Jan 2027 expected | urothelial carcinoma | Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotics Compound (Biolosion) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06904573 ↗ |
| Route | Oral | “15g, PO, qd” NCT06904573 ↗ |